poisar

Stocks · News reference

Arrowhead Pharmaceuticals Reports 2026 Fiscal Year-End Results

Fiscal.ai

Arrowhead Pharmaceuticals announced its financial results for the fiscal year ended September 30, 2026, and hosted a conference call to discuss the company's performance.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading